Krynica Vitamin S.A.

Total Valuation

Krynica Vitamin S.A. carries a market capitalization of 156.81M, placing it among publicly traded companies globally. Its enterprise value stands at 144.91M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Krynica Vitamin S.A. currently has 12.25M shares outstanding.

Valuation Ratios

Krynica Vitamin S.A. trades at a trailing price-to-earnings ratio of 7.70. The price-to-sales ratio is 0.29, and the price-to-book ratio stands at 3.49.

Enterprise Valuation

On an enterprise value basis, Krynica Vitamin S.A. trades at an EV/EBITDA multiple of 7.55 and an EV/FCF ratio of 2.87. The EV/Sales ratio of 0.38 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 7.55 provides insight into valuation relative to core operating earnings.

Financial Position

Krynica Vitamin S.A. maintains a current ratio of 0.82, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 36.78, indicating elevated leverage, while an interest coverage ratio of 6.10 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Krynica Vitamin S.A. posts a return on equity of 67.90 and a return on invested capital of 12.64.

Taxes

Over the trailing twelve months, Krynica Vitamin S.A. has paid 1.82M in income taxes, reflecting an effective tax rate of 11.29.

Stock Price Statistics

Krynica Vitamin S.A.'s stock has gained approximately 30.0813% over the past 52 weeks. The 50-day moving average sits at 12.91, while the 200-day moving average is 11.34.

Income Statement

Over the trailing twelve months, Krynica Vitamin S.A. generated 385.32M in revenue and converted that into 14.29M in net income, yielding earnings per share of 1.17. EBITDA reached 19.19M, while operating income came in at 19.19M.

Balance Sheet

Krynica Vitamin S.A. holds 48,000.00 in cash and equivalents against 34.92M in total debt, resulting in a net debt position of 31.10M. Total book value stands at 31.53M, with working capital of -19.98M providing operational flexibility.

Cash Flow

Krynica Vitamin S.A. produced 36.65M in operating cash flow over the past twelve months. After subtracting -11.11M in capital expenditures, free cash flow totaled 25.55M - equivalent to 2.09 per share.

Margins

Krynica Vitamin S.A. operates with a gross margin of 17.02, reflecting its pricing power and cost economics. The operating margin of 4.98 and net profit margin of 3.71 provide insight into operational efficiency.

Dividends & Yields

Scores

Krynica Vitamin S.A. posts an Altman Z-Score of 2.56, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.